Acute Assessment 2. Cardiovascular System Guidelines
Anticoagulation Guidance
BNSSG DOAC decision aid March 2020
BNSSG Summary of considerations when prescribing a DOAC
Anticoagulant and antiplatelet co–prescribing information
BNSSG Anticoagulation questions and answers July 2013
NBT DOAC counselling checklist
NICE KTT16 Anticoagulants including DOACs
UHB Anticoagulants counselling
BNSSG guidance on coagulopathy, thrombosis prevention and DIC for COVID-19 positive patients
Anticoagulation Patient Information Leaflets
Anticoagulation in AF
Apixaban- A Guide for patients with Atrial Fibrillation
Dabigatran- A guide for patients with Atrial Fibrillation
Rivaroxaban- A Guide for patients with Atrial Fibrillation
Anticoagulation in DVT
Anticoagulation choices leaflet v2 in DVT June 15 –final – for printing (rotated version)
Anticoagulation choices v2 in DVT June 15–final unrotated
Antiplatelet Guidance
Antiplatelet Guidelines May 17 BNSSG
Statin Guidance
BNSSG Management of Blood Lipid Levels (Statin Guidelines) 2020
Heart Failure Guidance
Primary care heart failure guidelines
Raynaud's Phenomenon
Due to significant disruption with the supply of a number of Nifedipine preparations, see local advice document on alternative options for the management of Raynaud's Phenomenon, available here
Medical Management of Raynauds Phenomenon in view of Nifedipine supply changes (Nov 19).pdf